A drug developed to fight also could be used in the future for the treatment of multiple sclerosis (MS), has been said.
low dose naltrexone (LDN) is not currently licensed to treat the condition as complete clinical trials have not yet been carried out and is available only under prescription of doctors.
The Daily Express has praised the drug as a “wonder drug” asserting that helps relieve some of the side effects of MS patients and citing a chief pharmacist indicating research indicates that alters how the body reacts to inflammation.
told the newspaper, former bank manager Linda Elsegood, who has multiple sclerosis, said internet toured a way to relieve the symptoms of their condition and met the LDN therapy.
a low dose of the drug private prescription had helped relieve some of your symptoms, including cognitive impairments, balance problems and difficulty swallowing, just three weeks after taking it.
“LDN is not a cure for MS, but has given me a life rather than a life,” he said.
Ms. Elsegood, who lives in Buxton and has two daughters, he founded a charity called the LDN Research trust in order to help others with MS and is pressing clinical trials are conducted for the condition .
Since 2004, the non-profit organization has helped 16,000 people to obtain the drug for the treatment of autoimmune disorders, including Crohn’s disease, syndrome irritable, cancer intestine and ME, as well as multiple sclerosis .
costs less than £ 30 per month per patient, LDN is approved for the treatment of alcohol and heroin addiction and takes on a much higher dose in these cases than those found to help alleviate MS symptoms.
MS is an incurable neurological autoimmune disease that affects the central nervous system. More than 100,000 people in the UK have MS and has a wide range of symptoms, with each affected differently by the disease.
This article was originally published on barchester, Read the original article here
Posted in: Multiple sclerosis